Millennium Management’s SAGENT PHARMACEUTICALS INC COM STK (DE) SGNT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
Sell
-327,021
Closed -$3.98M 3891
2016
Q1
$3.98M Sell
327,021
-376,515
-54% -$5.28M 0.01% 1381
2015
Q4
$11.2M Buy
703,536
+108,045
+18% +$1.7M 0.02% 869
2015
Q3
$9.13M Buy
595,491
+287,210
+93% +$6.21M 0.02% 983
2015
Q2
$7.49M Sell
308,281
-17,888
-5% -$429K 0.01% 1152
2015
Q1
$7.58M Sell
326,169
-46,889
-13% -$1.24M 0.01% 1184
2014
Q4
$9.37M Buy
373,058
+166,095
+80% +$4.87M 0.02% 1027
2014
Q3
$6.44M Sell
206,963
-198,836
-49% -$5.39M 0.02% 1129
2014
Q2
$10.5M Sell
405,799
-191,632
-32% -$4.26M 0.03% 799
2014
Q1
$14M Buy
597,431
+247,295
+71% +$5.41M 0.04% 614
2013
Q4
$8.89M Sell
350,136
-145,481
-29% -$3.29M 0.03% 791
2013
Q3
$10.1M Buy
495,617
+321,548
+185% +$7.16M 0.03% 675
2013
Q2
$3.65M Buy
+174,069
New +$3.11M 0.01% 1221

Other funds holding SGNT

Millennium Management's SGNT Position: Q2 2016 in Review

Millennium Management sold out of SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) in Q2 2016, closing a stake of 327,021 shares — an estimated $3.98M sold.

Millennium Management first reported a position in SGNT in Q2 2013 and held it in 12 quarters. The position peaked at $14M in Q1 2014. 128 funds tracked by Wall St. Rank hold SGNT as of Q2 2016.

  • Millennium Management reported no remaining SAGENT PHARMACEUTICALS INC COM STK (DE) position as of Q2 2016 after selling out during the quarter.
  • Millennium Management sold 327,021 SAGENT PHARMACEUTICALS INC COM STK (DE) shares in Q2 2016, an estimated $3.98M.
  • Millennium Management first reported a position in SAGENT PHARMACEUTICALS INC COM STK (DE) in Q2 2013 and held it in 12 quarters.
  • Millennium Management's SAGENT PHARMACEUTICALS INC COM STK (DE) position peaked at $14M in Q1 2014.
  • 128 funds tracked by Wall St. Rank held SAGENT PHARMACEUTICALS INC COM STK (DE) as of Q2 2016.

Based on Millennium Management's 13F filing for Q2 2016, filed 15 Aug 2016.